YSYvemarie B. O. Somsen

Yvemarie B. O. Somsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yvemarie B. O. Somsen has a total of 162 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Role and Assessment of Lipid Profile in Patients With a Chronic Total Coronary Occlusion

    by Karol Sadowski, Dominika Tomkiel, Roel Hoek, Ruben W. de Winter, Nick S. Nurmohamed, Bimmer E. P. M. Claessen, Niels J. Verouden, Alexander Nap, Sebastiaan A. Kleijn, Mariusz Tomaniak, et al.

    Adequate lipid management is a crucial component in the treatment of chronic coronary syndromes, a group of conditions that also encompasses patients with chronic total coronary occlusions (CTOs). Importantly, atherosclerotic progression may be especially rapid in patients with a CTO, yet it is unknown whether specific lipid thresholds for this population are appropriate or need to be adjusted compared to non‐CTO patients. The present review aimed to provide insight into the lipid profiles of CTO patients and their association with clinical outcome compared to non‐CTO patients. Furthermore, we investigated the impact of lipid levels on coronary collateral circulation (CCC) development. The available data suggest a tendency towards a more adverse lipid profile in CTO patients compared with non‐CTO patients, characterized by elevated TG, Lp(a), and AIP, and reduced HDL levels. While lipid parameters are frequently reported as baseline characteristics, few studies have directly evaluated their prognostic significance. The current evidence supports the hypothesis that a greater atherogenic burden in CTO patients may be associated with worse clinical outcomes and poorer CCC formation, particularly when advanced lipidomic markers or composite indices are considered. If confirmed in larger prospective studies, incorporating a more comprehensive assessment of the lipid profile into the clinical management of CTO patients may improve risk stratification and provide a basis for more personalized lipid‐lowering strategies in this high‐risk population.

  • Open Access

    Non-invasive hybrid functional and anatomical imaging for guiding revascularization decision-making by the heart team in patients with prior coronary artery bypass grafting

    by Roel Hoek, Ruben W. de Winter, Nils R. Planken, Yvemarie B.O. Somsen, Ruurt A. Jukema, Pieter G. Raijmakers, Jos W. Twisk, Pepijn A. van Diemen, Roel S. Driessen, Ibrahim Danad, et al.

  • Open Access

    Longitudinal results from a dedicated chronic total coronary occlusions percutaneous coronary intervention program—a single-center experience

    by Yvemarie B. O. Somsen, Rohan S. Mansaram, Roel Hoek, Camila S. Pizarro Perez, Dicky K. Y. Yee, Stefan P. Schumacher, Wynand J. Stuijfzand, Jos W. R. Twisk, Bimmer E. P. M. Claessen, Niels J. Verouden, et al.

    Objective: To provide insight into the longitudinal (> 10 years) results of a dedicated CTO PCI program in a single center. Background: Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) requires substantial operator experience. Dedicated CTO programs aim to increase technical success rates through sufficient case volume. However, longitudinal data beyond 10 years on such programs are scarce. Methods: We included 1185 patients who underwent CTO PCI in the Amsterdam University Medical Center between 2013 and 2024. Technical CTO PCI success was defined as thrombolysis in myocardial infarction flow grade 3 and < 30% residual stenosis. Procedural success was defined as technical success in the absence of in-hospital major adverse cardiovascular events. Multivariable logistic regression analyses were used to identify predictors for technical success. Results: Mean age was 66 ± 11 years; 81% were male. Overall technical CTO PCI success (92%) and procedural success (87%) rates were high and consistent. We observed temporal changes in wire crossing time (31 [7–56] to 23 [5–67] minutes), contrast volume (360 ± 160 to 210 ± 101 mL), and procedural time (90 [60–130] to 121 [80–165] minutes). Additionally, MACE rate improved from 13% (in 2013–2015) to 7% (in 2021–2024). Age ≥ 65 years, prior CABG, three-vessel disease, and an intermediate to high J‑CTO score (≥ 2) predicted technical failure. Conclusions: This study reports the longitudinal (> 10 years) results of a dedicated CTO PCI program, which confirms that high technical CTO PCI and procedural success rates can be achieved by a single center.


  • Diagnostic Value of Relative Flow Reserve in Patients With Prior Coronary Artery Disease: A Post Hoc Analysis of the PACIFIC-2 Trial

    by Roel Hoek, Yvemarie B.O. Somsen, Ruben W. de Winter, Ruurt A. Jukema, Jos W. Twisk, Pieter G. Raijmakers, Ibrahim Danad, Juhani Knuuti, Paul Knaapen, Pepijn A. van Diemen, et al.

    BACKGROUND: The relative flow reserve (RFR) derived from quantitative myocardial perfusion imaging is the ratio of absolute myocardial perfusion in a stenotic to normally perfused area and is considered the noninvasive equivalent of fractional flow reserve (FFR). In patients with prior coronary artery disease (CAD), detecting hemodynamically significant CAD using hyperemic myocardial blood flow (hMBF) is complicated by diffuse CAD and microvascular disease. In these patients, RFR may improve the diagnostic performance of myocardial perfusion imaging. Therefore, we studied the diagnostic value of RFR over hMBF in patients with prior CAD. METHODS: The PACIFIC-2 trial (functional stress imaging to predict abnormal coronary FFR) included symptomatic patients with prior myocardial infarction and/or percutaneous coronary intervention who prospectively underwent [ 15 O]H 2 O positron emission tomography perfusion imaging and invasive coronary angiography with 3-vessel FFR. RFR was assessed using positron emission tomography in an overall cohort incorporating all trial patients, and an optimal cohort of patients with angiographic 1- or 2-vessel disease (diameter stenosis ≥50%) and a nonstenotic reference vessel (diameter stenosis P P =0.288) and the optimal cohort (0.79 versus 0.82; P =0.512). CONCLUSIONS: RFR proves clinically applicable, even without specific patient selection and knowledge of the coronary anatomy. However, RFR does not outperform absolute hyperemic myocardial perfusion for detecting FFR-defined significant CAD in patients with prior CAD and recurrence of symptoms.

  • Open Access

    Design and rationale of the drug-coated balloon coronary angioplasty versus stenting for treatment of disease adjacent to a chronic total occlusion (Co-CTO) trial

    by Yvemarie B.O. Somsen, Ruben W. de Winter, Jiawei Wu, Roel Hoek, Ralf W. Sprengers, Niels J. Verouden, Bimmer E.P.M. Claessen, Sebastiaan A. Kleijn, Jos W.R. Twisk, José P. Henriques, et al.


  • Open Access

    The Impact of Hydrostatic Pressure on Fractional Flow Reserve in Saphenous Vein Grafts

    by Roel Hoek, Sina Porouchani, Ruben W. de Winter, Yvemarie B. O. Somsen, Pepijn A. van Diemen, Ruurt A. Jukema, Jos W. Twisk, Adriaan Wilgenhof, Alexander W. Den Hartog, Niels J. Verouden, et al.

    Background: The relationship between height differences related to graft anatomy and physiological pressure indices in coronary bypass grafts has not been studied. We sought to study the impact of hydrostatic pressure on fractional flow reserve (FFR) in saphenous vein grafts (SVGs). Methods: Included were 66 symptomatic patients (76 SVGs) with prior coronary artery bypass grafting who underwent coronary computed tomography angiography (CCTA) preceding invasive coronary angiography with FFR interrogation of ≥ 1 SVGs. The graft course and height excursion were reconstructed based on CCTA images. The impact of hydrostatic pressure on FFR (corrected FFR) was calculated by adding or subtracting 0.077 mmHg to the distal coronary pressure for every millimeter height difference in a supine position between the SVG ostium and the pressure wire tip position. Results: The height difference (mm) between the SVG ostium and pressure wire tip position was largest for single SVGs to the circumflex artery (Cx; −55.1 ± 17.0), followed by sequential SVGs to the Cx (−51.8 ± 17.3) and the right coronary artery (RCA; −36.7 ± 21.6). The correlation between height difference and uncorrected FFR was −0.59 ( p < 0.001). Corrected FFR was lower as compared to uncorrected FFR in the overall cohort (0.86 ± 0.17 vs. 0.88 ± 0.18), in single SVGs to Cx (0.85 ± 0.17 vs. 0.90 ± 0.18), and in sequential SVGs to Cx (0.92 ± 0.14 vs. 0.96 ± 0.15) and RCA (0.82 ± 0.17 vs. 0.85 ± 0.21) ( p < 0.001 for all). Conclusions: Hydrostatic pressure related to height differences along the course anatomy of SVGs can impact FFR measurements, with corrected FFR being significantly lower in SVGs to the Cx and sequential SVGs to the RCA.


  • Open Access

    Comparison of Fractional Flow Reserve and Myocardial Perfusion Imaging in Saphenous Vein Grafts

    by Roel Hoek, Ruben W. de Winter, Rens T. Peters, Yvemarie B. O. Somsen, Pepijn A. van Diemen, Ruurt A. Jukema, Jos W. Twisk, Niels J. Verouden, Alexander W. Den Hartog, Pieter G. Raijmakers, et al.

    Background: Revascularization decision‐making for saphenous vein grafts (SVGs) relies on angiographic lesion severity estimation, as studies on fractional flow reserve (FFR) for detecting ischemia in SVGs are scarce.Aims: To compare FFR and quantitative coronary angiography (QCA) of SVGs against myocardial perfusion imaging (MPI) and to establish an optimal FFR threshold for SVGs.Methods: This cross‐sectional registry study included symptomatic patients with prior coronary artery bypass grafting who underwent single‐photon emission computed tomography, positron emission tomography, or stress perfusion cardiac magnetic resonance imaging and had FFR measurements of ≥ 1 SVGs. We matched the myocardial territory supplied by the SVGs to ischemia on MPI. The optimal FFR threshold for SVGs was determined using the Youden index. Diagnostic performance measures were calculated and compared for FFR (0.80 and the optimal threshold) and for QCA (diameter stenosis ≥ 50%).Results: This study included 80 patients (mean age 73 ± 7 years, 68 [85%] male) with 94 SVGs, of which 38 (40%) supplied ischemic myocardium. Areas under the curve between FFR and QCA were comparable (0.73 vs. 0.65, p = 0.181). The optimal cutoff value of FFR was 0.94. FFR ≤ 0.94 showed higher sensitivity (63%) and negative predictive value (75%) compared to FFR ≤ 0.80 (32% [p < 0.001] and 64% [p = 0.007]) and QCA (37% [p = 0.002] and 65% [p = 0.021]), but with lower specificity (75%) than FFR ≤ 0.80 (84%, p = 0.021). Positive predictive value and overall accuracy were similar across all methods.Conclusions: FFR and QCA had comparable moderate diagnostic performance for detecting SVG failure determined by MPI. The optimal FFR cutoff in SVGs is higher than 0.80, resulting in higher sensitivity and negative predictive value compared to FFR ≤ 0.80 and QCA, at the expense of reduced specificity.


  • Open Access

    Myocardium at risk in chronic total coronary occlusion territory collateralized by an infarct-related artery: The double jeopardy theory

    by Yvemarie B.O. Somsen, Roel Hoek, Ruben W. de Winter, Rocco Giunta, Stefan P. Schumacher, Henk Everaars, Wynand J. Stuijfzand, Niels J. Verouden, Bimmer E.P.M. Claessen, Alexander Nap, et al.